Monopar Therapeutics Inc.

NASDAQ: MNPR · Real-Time Price · USD
36.23
0.37 (1.03%)
At close: Aug 15, 2025, 2:35 PM

Monopar Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-16.16M -8.83M -10.54M -9.13M
Interest Income
404.02K 429.04K 21.24K 24.02K
Pretax Income
-15.59M -8.4M -10.52M -9.1M
Net Income
-15.59M -8.4M -10.52M -9.1M
Selling & General & Admin
3.16M 3.23M 2.94M 2.63M
Research & Development
13.01M 5.6M 7.59M 6.49M
Other Expenses
279.00 n/a n/a n/a
Operating Expenses
16.16M 8.83M 10.54M 9.13M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
16.16M 8.83M 10.54M 9.13M
Income Tax Expense
n/a n/a -21.24K -24.02K
Shares Outstanding (Basic)
3.79M 14.51M 12.72M 12.47M
Shares Outstanding (Diluted)
3.79M 14.51M 12.72M 12.47M
EPS (Basic)
-4.11 -0.58 -0.83 -0.73
EPS (Diluted)
-4.11 -0.58 -0.83 -0.73
EBITDA
-15.59M 429.04K -10.54M -9.13M
EBIT
-15.59M -8.4M -10.52M -9.1M
Depreciation & Amortization
16.16M 8.83M 10.54M 9.13M